Inflammatix is a San Francisco-based startup that develops diagnostic tests for acute infections and sepsis using unique immune biomarkers. Their HostDx™ tests provide clinically actionable information on the presence, type, and severity of infection in all patients, and have been extensively validated and published in top-tier medical journals. Their technology is faster and more effective than current methods, which focus on finding the specific pathogen causing the infection.